Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.
Godman
Brian
B
Schwabe
Ulrich
U
Selke
Gisbert
G
Wettermark
Björn
B
D016527:Drug Costs / Q000331:legislation & jurisprudence* / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors / Q000191:economics* / Q000627:therapeutic use*
D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D054328:Proton Pump Inhibitors